Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Integrated Nuclear Enterprises (INE) is a leading healthcare company based in the Philippines, specializing in the distribution and service of nuclear medicine products and radiopharmaceuticals. The company serves as a vital provider of diagnostic and therapeutic isotopes, including Iodine-131 and Technetium-99m generators, which are essential for oncology, cardiology, and endocrinology applications. INE maintains strategic partnerships with global leaders in the radiopharmaceutical industry, such as Curium, to ensure the availability of high-quality medical tracers and imaging kits. In addition to product supply, the company provides technical support, equipment maintenance, and consultancy services for nuclear medicine departments in hospitals across the region. Their portfolio includes a wide range of 'cold kits' used for organ-specific scintigraphy and specialized imaging procedures. As a key player in the local medical infrastructure, INE facilitates advanced diagnostics and targeted radionuclide therapy for patients nationwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Integrated Nuclear Enterprises.